Eric Rose
Follow
Get notifications in MyBN when activity occurs.
Eric Rose
Executive Director, Chief Medical Officer / Mesoblast
Dr Eric Rose has experience as a surgeon, researcher and businessman; and has medical, pharmaceutical, scientific and industry expertise.
Dr Rose led the Columbia Presbyterian heart transplantation program in the United States from 1982 to 1992. He went on to become chair of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital from 1994 to 2007, and an Edmond A Guggenheim Professor and chair of the Department of Health Evidence and Policy at the Mount Sinai School of Medicine from 2008 to 2012.
Dr Rose led the Columbia Presbyterian heart transplantation program in the United States from 1982 to 1992. He went on to become chair of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital from 1994 to 2007, and an Edmond A Guggenheim Professor and chair of the Department of Health Evidence and Policy at the Mount Sinai School of Medicine from 2008 to 2012.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 701st | K-TIG | 0% | 105% |
| 1328th | Atomo Diagnostics | -40% | |
| 1451st | Phoslock Environmental Technologies | -49% | -42% |
| 1728th | Mesoblast | -68% | -24% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 754th |  | Mesoblast | $13.3m |
| 882nd | | Phoslock Environmental Technologies | $3.9m |
| 883rd | | K-TIG | $3.7m |
| 885th | | Atomo Diagnostics | $3.6m |
| 886th | | Leaf Resources | $3.6m |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
